PAR 0.00% 24.5¢ paradigm biopharmaceuticals limited..

Yeah I meant our protocol for stage 2 002 was 470 (see below)...

  1. 4,137 Posts.
    lightbulb Created with Sketch. 6621
    Yeah I meant our protocol for stage 2 002 was 470 (see below) and 003 was in at about 720... (I thought you might be inferring 470 plus 720 was 1190 (close enough to 1200) which might now be 600). Thats too low in my view across both.

    Im hoping they will cut some off each number...?


    https://hotcopper.com.au/data/attachments/6022/6022746-9577e1c8cfc55944931becfd1b62fd6b.jpg


    (SIngle left click above image to enlarge)



    I think both of these numbers (for 002 stage 2 and 003) have a chance of being reduced. Torpy brings up a good point of how many placebo we would need in stage 2 and 003 but you could also make an argument that you still need a fresh set cos the dose is different compared to anything in stage 1? (Yes 005 and 008 programs are there but they are still Phase 2B studies).

    Im hopeful n will be reduce in the new protocol nevertheless, but to what extent, we just have to wait and see.




    Ref:
    https://classic.clinicaltrials.gov/ct2/show/NCT04809376
    Last edited by Mozzarc: 10/03/24
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
(20min delay)
Last
24.5¢
Change
0.000(0.00%)
Mkt cap ! $85.7M
Open High Low Value Volume
24.5¢ 24.5¢ 24.5¢ $31.10K 126.9K

Buyers (Bids)

No. Vol. Price($)
6 146333 24.5¢
 

Sellers (Offers)

Price($) Vol. No.
25.0¢ 50464 4
View Market Depth
Last trade - 16.10pm 07/06/2024 (20 minute delay) ?
Last
25.0¢
  Change
0.000 ( 2.04 %)
Open High Low Volume
24.5¢ 25.0¢ 24.5¢ 58268
Last updated 15.27pm 07/06/2024 ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.